Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,23,1.03 [0.88-1.21],0.696416187565959
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,23,0.96 [0.88-1.05],0.419316103858051
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,23,1.03 [0.98-1.07],0.236194665242415
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,23,1.13 [0.70-1.82],0.624120270073786
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,23,1.02 [0.94-1.11],0.605373513840248
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other viral diseases,Inverse variance weighted,23,0.97 [0.88-1.06],0.458378277881413
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,23,0.78 [0.38-1.60],0.497748224894039
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,23,0.98 [0.92-1.03],0.422757657923826
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,23,0.98 [0.91-1.05],0.510656035668626
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,23,0.97 [0.91-1.04],0.437202505357107
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,23,0.84 [0.65-1.10],0.213032731953935
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,23,1.11 [1.01-1.22],0.0275274842891559
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,23,1.06 [0.92-1.21],0.409038485173071
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,23,1.06 [0.98-1.14],0.173752200788803
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,23,1.02 [0.96-1.10],0.502848961158476
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,23,1.03 [0.95-1.12],0.457137288761231
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,23,1.00 [0.94-1.07],0.932426177208868
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,23,0.92 [0.85-1.00],0.0460179996503075
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,23,0.96 [0.92-1.01],0.132594682366129
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,23,0.98 [0.94-1.02],0.299908072687689
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,23,1.00 [0.96-1.04],0.964781211585575
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,Alcohol dependence,Inverse variance weighted,23,1.03 [0.94-1.12],0.541313405817391
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,Depression,Inverse variance weighted,23,1.01 [0.96-1.06],0.695423762080926
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,Depression or dysthymia,Inverse variance weighted,23,0.99 [0.94-1.03],0.546249208892183
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,23,0.99 [0.95-1.03],0.645325865591189
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,23,0.97 [0.89-1.05],0.402866062003301
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,23,0.99 [0.92-1.06],0.75658027339125
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,23,1.01 [0.95-1.08],0.663911384013465
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,23,1.05 [0.87-1.25],0.625004344497849
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,23,1.03 [0.97-1.08],0.343726665754246
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,23,0.99 [0.92-1.08],0.87437167401691
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,23,1.00 [0.95-1.06],0.903480709287891
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,23,0.98 [0.92-1.04],0.484627623326841
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,23,1.01 [0.97-1.05],0.642497250853197
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,23,1.01 [0.96-1.05],0.770417495377757
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,23,0.77 [0.47-1.28],0.317576890931532
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,23,1.02 [0.79-1.30],0.895741561575979
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,23,1.01 [0.97-1.06],0.560761896976117
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,23,1.00 [0.93-1.09],0.921073320576679
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,23,1.01 [0.94-1.09],0.816544141194809
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,23,1.11 [0.91-1.36],0.300184804089033
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,23,0.84 [0.69-1.03],0.0869200206932886
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,23,0.90 [0.71-1.13],0.362110231352312
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,23,0.97 [0.92-1.02],0.191556350448521
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,Inverse variance weighted,23,1.04 [0.97-1.12],0.304223428876268
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,23,0.95 [0.89-1.01],0.125643217648729
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,23,0.99 [0.88-1.11],0.838375558571649
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,23,1.14 [0.96-1.35],0.149083302877921
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,23,0.96 [0.83-1.12],0.634157589231702
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,23,0.97 [0.93-1.02],0.232009842739239
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,23,1.00 [0.96-1.04],0.977141732395793
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,23,1.00 [0.96-1.03],0.844168671689047
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,23,1.03 [0.97-1.09],0.32431416695177
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,23,1.04 [0.97-1.11],0.243587163531371
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,23,1.12 [0.97-1.29],0.128102247897302
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,23,0.96 [0.92-1.01],0.0829947923314859
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,23,1.00 [0.88-1.13],0.944245728992756
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,23,0.98 [0.92-1.04],0.507814697130188
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,23,1.04 [1.00-1.08],0.0705923248197369
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,23,1.05 [0.96-1.14],0.304865955277602
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,23,0.99 [0.96-1.03],0.64015587076855
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,Inverse variance weighted,23,1.06 [0.98-1.14],0.174551734410085
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,23,1.03 [0.94-1.12],0.570083450100102
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,23,1.04 [0.96-1.13],0.310510911326215
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,23,1.03 [0.94-1.14],0.505903151622455
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,23,0.98 [0.94-1.02],0.296704442095696
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,23,0.96 [0.91-1.02],0.15152328804118
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,Inverse variance weighted,23,1.11 [1.01-1.22],0.0245554434032099
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,23,1.02 [0.98-1.05],0.371650457166054
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,Inverse variance weighted,23,1.00 [0.93-1.07],0.905856361645344
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,23,1.00 [0.97-1.03],0.992402978523277
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,23,1.00 [0.96-1.04],0.950556532322836
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,Inverse variance weighted,23,1.02 [0.97-1.09],0.429492955315824
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,23,0.98 [0.91-1.05],0.551656595937869
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,23,0.97 [0.88-1.06],0.4818772220107
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,23,1.05 [1.00-1.10],0.05030980711665
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,23,1.13 [1.01-1.26],0.034620232655279
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,23,1.02 [0.99-1.05],0.205955731092925
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,23,1.03 [0.97-1.08],0.35408334986404
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,23,0.98 [0.89-1.09],0.707201411386142
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,23,0.98 [0.89-1.07],0.661763279398193
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,23,0.98 [0.93-1.02],0.330173440198448
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,23,0.97 [0.83-1.13],0.70256020753861
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,23,0.98 [0.93-1.04],0.497088275367521
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,23,0.98 [0.94-1.02],0.240182802326895
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,23,1.11 [0.93-1.32],0.260767492644528
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,23,1.15 [1.03-1.30],0.0174126344251717
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,23,1.16 [0.97-1.38],0.0958538904093057
